Innate Pharma (IPH.PA) Q3 2024 Earnings

12SepConfirmed
Q3 2023
Q1 2024
Q1 2024
Q3 2024
-0.41
-0.31
-0.22
-0.12

Details

Expected EPS
-0.270755999808
Actual EPS
-0.299765571216
Surprise EPS
-0.03
Surprise Percent
+10.71%

Description

Innate Pharma (IPH.PA) has reported earnings of -0.299765571216 per share for Q3 2024.

0 Comments

Share your thoughts